? More than a year after Aya Jakobovits abruptly vacated the CEO office, Adicet Bio has found her permanent successor just ahead of its first IND. Anil Singhal takes over from Donald Santel, the executive chairman who?s been filling the role. An AbbVie vet, Singhal joins the immunotherapy company with some fresh biotech experience as executive-in-residence at Canaan Partners and CSO of OncoResponse.
? At the beginning of this year,